Sanofi's Tzield Prescribed in Boao Lecheng to Delay Onset of Type 1 Diabetes
CompanyDrug

Sanofi’s Tzield Prescribed in Boao Lecheng to Delay Onset of Type 1 Diabetes

Allgens Medical's SkuHeal Artificial Bone Repair Material Gains Vietnam Marketing Approval
CompanyMedical Device

Allgens Medical’s SkuHeal Artificial Bone Repair Material Gains Vietnam Marketing Approval

Clover Biopharmaceuticals Completes Enrollment for Phase I Trial of RSV + hMPV Combination Vaccines
CompanyDrug

Clover Biopharmaceuticals Completes Enrollment for Phase I Trial of RSV + hMPV Combination Vaccines

Shanghai Henlius Biotech Partners with Shanghai Chest Hospital for Clinical Research and Talent Development
CompanyDeals

Shanghai Henlius Biotech Partners with Shanghai Chest Hospital for Clinical Research and Talent Development

RemeGen's Telitacicept Receives Orphan Drug Designation for Myasthenia Gravis in Europe
CompanyDrug

RemeGen’s Telitacicept Receives Orphan Drug Designation for Myasthenia Gravis in Europe

Yunnan Baiyao's JZ-14 Gets NMPA Clinical Clearance for Ulcerative Colitis Trial
CompanyDrug

Yunnan Baiyao’s JZ-14 Gets NMPA Clinical Clearance for Ulcerative Colitis Trial

Johnson & Johnson Submits sBLA to Expand Stelara Use for Pediatric Crohn's Disease
CompanyDrug

Johnson & Johnson Submits sBLA to Expand Stelara Use for Pediatric Crohn’s Disease

Suzhou Zelgen Gains NMPA Approval for ZG005 and ZG006 Combination Trial in Advanced Cancers
CompanyDrug

Suzhou Zelgen Gains NMPA Approval for ZG005 and ZG006 Combination Trial in Advanced Cancers

Mindray Bio-Medical Expands North American Warehouse to Enhance Operational Efficiency
CompanyMedical Device

Mindray Bio-Medical Expands North American Warehouse to Enhance Operational Efficiency

GSK Launches 'Linked by Lupus' Initiative to Support Lupus Care with $1M Funding
Company

GSK Launches ‘Linked by Lupus’ Initiative to Support Lupus Care with $1M Funding

Bayer Files NDA for Gadoquatrane, Aiming to Offer Lowest-Dose GBCA in the U.S.
CompanyDrug

Bayer Files NDA for Gadoquatrane, Aiming to Offer Lowest-Dose GBCA in the U.S.

EpimAb Biotherapeutics Submits Hong Kong IPO Application as Biotech Expands
CompanyDeals

EpimAb Biotherapeutics Submits Hong Kong IPO Application as Biotech Expands